Quantcast Pharmaceutical Industry News - Congoo
Log In
  COMPLETE INDUSTRY LIST >> PHARMACEUTICAL INDUSTRY    Get our Pharmaceutical Industry daily Briefing     
Advertising industry
Aerospace & defense
Aerospace related
Airline industry
Automotive industry
Biological sciences
Book publishing
Broadcasting industry
Business related
Cable industry
Chemicals industry
Clothing industry
Communications equipment
Computer games
Computer security
Corporate finance
Corporate governance
Crime & Punishment
Database industry
Digital television
Emerging markets
Engineering Industry
Engineering General
Enterprise computing
Equity markets
European business
Fed watch
Finance news
Firearms industry
Food industry
Forex markets
Fund management
Graphics industry
Hospitality industry
Human resources
Human rights
Human sciences
Imaging equipment
Insurance industry
Internet consultancies
Internet Europe
Internet news
IP and patents
Job markets
Knowledge management
Law related
Leisure goods
Mergers & acquisitions
Metals industry
Mining and metals
Mobile industry
Mortgage industry
Movie business
Music business
Mutual funds
Newspaper publishing
Oil & gas
Online banking
Online broker
Online content
Online information
Online legal issues
Online marketing
Online portals
Open source
Packaging & paper
Packaging related
PC industry
PC software
Personal data privacy
Personal finance
Personal technology
Pharmaceutical Industry
Physical Sciences
Plastics industry
Public health
Real Estate industry
Retail investor
Retail sector
Securities industry
Semiconductor industry
Shipping industry
Silicon Valley
Small business
Software downloads
Space science
Stock Exchanges
Tech stocks
Technology news
Telecom industry
Textiles related
Tobacco industry
Transportation industry
Transportation related
Travel industry
UK law
US education
US immigration
US politics
US security
US social policy
Utilities News
Venture Capital
Web developer
Web services
Webmaster tips
Website owner
Windows OS
Wireless sector
XML & metadata

Supervisory Wildlife Biologist - USA-IA-Urbandale   - 4 Hours ago
About EnvironmentGuru EnvironmentGuru.com is the largest online Social Network that offers a place for environmental professionals around the world to collaborate, find, and distribute environmental
all 97762 news articles >>

Epirus Biopharmaceuticals Trading Up 4.4% (EPRS)   - 7 Hours ago
Epirus Biopharmaceuticals (NASDAQ:EPRS) shares were up 4.4% on Friday , MarketBeat.com reports. The stock traded as high as $5.07 and last traded at $5.00, with a volume of 57,237 shares. The stock had
all 194 news articles >>

Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/NF-?B Pathway   - 11/22/2015
Abstract Evodiamine (Evo), extracted from the Chinese herbal medicine Evodia rutaecarpa, has cytotoxic effects on different types of human cancer cells. However, its effects on drug resistance and their

Accuray Shares Up 2.6% (ARAY)   - 12 Hours ago
Shares of Accuray (NASDAQ:ARAY) shot up 2.6% during trading on Friday , AnalystRatingsNetwork.com reports. The company traded as high as $7.09 and last traded at $7.04, with a volume of 202,884 shares
all 78 news articles >>

Vocera Communications Reaches New 12-Month High at $13.51 (VCRA)   - 7 Hours ago
Vocera Communications (NASDAQ:VCRA) shares reached a new 52-week high during trading on Friday , Analyst Ratings.Net reports. The stock traded as high as $13.51 and last traded at $13.33, with a volume
all 273 news articles >>

Investors Sell J M Smucker on Strength on Insider Selling (SJM)   - 11/24/2015
Investors sold shares of J M Smucker (NYSE:SJM) on strength during trading hours on Monday after an insider sold shares in the company, AnalystRatings.Net reports. $28.11 million flowed into the stock
all 32 news articles >>

Your sponsored post can go right here! Sponsored

Congoo’s B2B information portal now receives over 1 million visits per month.  Congoo provides a highly influential audience comprehensive news and information within their industry.  Reach a coveted audience of senior executives, affluent males and opinion leaders. Get the Media Kit

Investors Sell Zoetis on Strength (ZTS)   - 11/26/2015
Traders sold shares of Zoetis (NYSE:ZTS) on strength during trading on Wednesday, Analyst Ratings Network.com reports. $9.51 million flowed into the stock on the tick-up and $54.55 million flowed out
all 22 news articles >>

Exercise can reduce heart failure risk   - 11/22/2015
Starting to exercise later in life can still reduce your risk of heart failure, and even modest increases in activity could provide some protection, researchers said. "Our findings suggest that when
all 4 news articles >>

Amazon 'Cyber Monday' 2015 Deals: How Good Are They?   - 3 Hours ago
© 2015 TeleTrader Software GmbH. All rights reserved. Take account of the Terms of Use . Teletrader is not affiliated with Charles Schwab & CO., Inc. The price information is time delayed to varying
all 7909 news articles >>

Ernst & Young - The right transaction Sponsored
No matter what the size of your company, where it is located or the business you are in, transactions can help your company grow, prosper or reinvent itself. The Ernst and Young Transaction professionals can play a critical role at every step of the deal lifecycle.  Learn More

Martin Shkreli, major shareholder of KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)   - 11/22/2015
Martin Shkreli Insider Buy Transaction After the disclosing of a public form filled with SEC; a telling investment became apparent. The major shareholder of KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)
all 4 news articles >>

Eagle Pharmaceuticals Downgraded by Vetr Inc. (EGRX)   - 11/22/2015
Filed Under: Analysts Downgrades • Market News Eagle Pharmaceuticals (NASDAQ:EGRX) was downgraded by Vetr from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday,

Jefferies Group Increases Abbott Laboratories Price Target to $49.00 (ABT)   - 11/22/2015
Filed Under: Analysts Price Targets • Market News Abbott Laboratories (NYSE:ABT) had its price objective lifted by equities research analysts at Jefferies Group to $49.00 in a research report issued

Reach your target audience with AdBlade! Sponsored
- Brand your product
- Create awareness in your product
- Drive traffic

And do it all on a CPC basis of as little as 50 cents.  Try AdBlade and begin reaching your targ.  Learn More

Ladder Capital Corp Receives $20.25 Consensus Price Target from Brokerages (NASDAQ:LADR)   - 11/26/2015
Shares of Ladder Capital Corp (NASDAQ:LADR) have earned an average recommendation of “Buy” from the six analysts that are currently covering the stock, Marketbeat reports. One research analyst has rated
all 22 news articles >>

Alexion Pharmaceuticals Downgraded by Vetr Inc. (ALXN)   - 11/22/2015
Alexion Pharmaceuticals (NASDAQ:ALXN) was downgraded by equities research analysts at Vetr from a “strong-buy” rating to a “buy” rating in a research note issued on Wednesday, AnalystRatings.NET reports.

Gilead Sciences Rating Lowered to Buy at Vetr Inc. (GILD)   - 11/22/2015
Gilead Sciences (NASDAQ:GILD) was downgraded by Vetr from a “strong-buy” rating to a “buy” rating in a research note issued on Wednesday, Market Beat Ratings reports. They presently have a $120.29 target
all 21 news articles >>

UBS AG Lowers Ctrip.com International to Neutral (CTRP)   - 11/25/2015
November 25th, 2015 • 0 comments • Filed Under • by Filed Under: Market News Ctrip.com International (NASDAQ:CTRP) was downgraded by investment analysts at UBS AG from a “buy” rating to a “neutral”
all 24 news articles >>

Imprimis Pharmaceuticals Trading Up 14.7% (IMMY)   - 11/22/2015
Imprimis Pharmaceuticals (NASDAQ:IMMY) shares were up 14.7% on Friday , AnalystRatings.Net reports. The stock traded as high as $6.15 and last traded at $5.86, with a volume of 64,556 shares. The stock

Merck Announces Initial Results for KEYTRUDA with Novel Immunotherapy Combinations   - 11/22/2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc. Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes. Markets are closed on certain holidays. Stock

Le Bonheur to test promising new drug on babies battling RSV [The Commercial Appeal,   - 11/22/2015
Nov. 21In the wake of a successful trial involving adult volunteers, Le Bonheur Children's Hospital this winter will begin testing a promising new medicine on babies infected with the previously untreatable

Biohaven Appoints Vlad Coric M.D. as Chief Executive Officer [Kuwait News Agency]   - 11/22/2015
(PRWeb) - The Board of Directors of Biohaven Pharmaceutical Holding Company Limited (d/b/a Biohaven) is pleased to announce the election of Vlad Coric, M.D. as Chief Executive Officer. Dr. Coric has had
all 2 news articles >>

James Geraghty, director of Juniper Pharmaceuticals Inc (NASDAQ:JNP) Just Bought   - 11/22/2015
James Geraghty Insider Buy Transaction James Geraghty who is the present director of Juniper Pharmaceuticals Inc (NASDAQ:JNP) 11.62 +0.15 1.31% recently acquired 8,000 shares of the Massachusetts-based

Insider Investment: Juniper Pharmaceuticals Inc (NASDAQ:JNP)’s President & CEO Frank   - 11/22/2015
Frank Condella Insider Buy Transaction According to an electronic report that’s filled with the U.S. Security & Exchange Commission on November 19, 2015, Frank Condella an insider in Juniper Pharmaceuticals

EMCORE Shares Up 3.7% (EMKR)   - 11/22/2015
EMCORE (NASDAQ:EMKR)’s share price shot up 3.7% during trading on Friday , Market Beat.com reports. The stock traded as high as $7.38 and last traded at $7.34, with a volume of 297,219 shares trading
all 1 news articles >>

Merck Announces Initial Results for Pembrolizumab with Novel Immunotherapy Combinations   - 11/22/2015
Merck Canada Inc. (via noodls) / Merck Announces Initial Results for Pembrolizumab with Novel Immunotherapy Combinations from Three Investigational Studies Presented at the Society for Melanoma Re [...]

Charles O’keeffe just Picked up 5,000 shares of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX),   - 11/22/2015
Charles O’keeffe Insider Buy Transaction As exposed in the Washington-based SEC, a form for the purchase of 5,000 shares of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) 2.43 +0.03 1.25% by Charles O’keeffe
*Votes may take up to 30 minutes to influence article rank order
Featured Members
Joan Bradley Joan Bradley
Pharma Industry
John Caminis John Caminis
Vice President Clinical Development
Pharma Industry
Neil Berliner, M.D. Neil Berliner, M.D.
Pharma Industry
Allison Gerard Allison Gerard
Research Director
Pharma Industry

  Add your Profile
  View more profiles


Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2015 Congoo.com. All Rights Reserved.